MITOBRIDGE
Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions. Building upon the emerging scientific findings linking mitochondrial dysfunction with disease pathologies, the Company is progressing innovative approaches to the treatment of diseases with a high unmet medical need. Their strategy is to establish proof of concept in rare diseases and then expand into more common diseases. Mitobridge has assembled a strong team with expertise in advancing g... round-breaking therapeutics into the clinic. Their scientific founders and advisors include leaders in mitochondrial biology, metabolism, and aging with experience in translating novel discoveries into next-generation medicines. The Company was founded in October of 2013 with financing from MPM Capital, Longwood Fund, and Astellas Pharma and a shared vision for the promise of mitochondrial-targeted therapeutics.
MITOBRIDGE
Industry:
Biotechnology Life Science Therapeutics
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.mitobridge.com
Total Employee:
11+
Status:
Active
Contact:
(617)401-9100
Email Addresses:
[email protected]
Total Funding:
5.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Universal Analytics Font Awesome Apache
Current Employees Featured
Founder
Investors List
MPM Capital
MPM Capital investment in Series A - Mitobridge
Astellas Pharma
Astellas Pharma investment in Series A - Mitobridge
Longwood Fund
Longwood Fund investment in Series A - Mitobridge
MPM Capital
MPM Capital investment in Seed Round - Mitobridge
Official Site Inspections
http://www.mitobridge.com
- Host name: slab500.com
- IP address: 209.68.21.212
- Location: Pittsburgh United States
- Latitude: 40.4236
- Longitude: -79.9825
- Metro Code: 508
- Timezone: America/New_York
- Postal: 15203
